Skip to main content

Usman R. Siddiqui, MD

Usman R. Siddiqui , MD

Electrophysiologist

Transplant

Usman Siddiqui

Overview

Usman Rasheed Siddiqui, MD, is a board-certified cardiologist with training in internal medicine, cardiovascular disease, clinical care electrophysiology and nuclear cardiology. After earning his medical degree from Dow Medical College in Pakistan, Dr. Siddiqui completed his internal medicine residency at both the University of Iowa in Iowa City and the Cleveland Clinic in Ohio. He completed his clinical cardiac electrophysiology fellowship at University of Miami Miller School of Medicine. Dr. Siddiqui says his goal is always to treat patients like family and increase the quality of their lives.

Articles

Improved clinical outcomes associated with the Impella 5.5 compared to the Impella 5.0 in contemporary cardiogenic shock and heart failure patients

JOURNAL OF HEART AND LUNG TRANSPLANTATION

2023

Multicenter Registry Using Propensity Score Analysis to Compare a Novel Transport/Preservation System to Traditional Means on Postoperative Hospital Outcomes and Costs for Heart Transplant Patients

ASAIO JOURNAL

2023

The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support

JOURNAL OF CARDIAC FAILURE

2023

Evaluation of Latex Immunoturbidimetric Assay Thresholds and HIT in Cardiothoracic Surgery

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

2023

Safety and effectiveness of the first contact force ablation catheter with a flexible tip

HEART RHYTHM O2

2023

Health-Related Quality of Life in Older Patients With Heart Failure From Before to Early After Advanced Surgical Therapies: Findings From the SUSTAIN-IT Study

CIRCULATION-HEART FAILURE

2022

Commentary: Orphan devices, orphan doctors, and orphaned patients

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

2022

Analysis of Bicarbonate-Based Purge Solution in Patients With Cardiogenic Shock Supported Via Impella Ventricular Assist Device

ANNALS OF PHARMACOTHERAPY

2022

Outcomes with Direct and Indirect Thrombin Inhibition during Extracorporeal Membrane Oxygenation for COVID-19.

ASAIO journal (American Society for Artificial Internal Organs : 1992)

2022

Center Variability in Patient Outcomes Following HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial.

Journal of cardiac failure

2022

Education & Training

Education

Dow Medical School

Residency

University Of Iowa; Cleveland Clinic Foundation

Fellowship

University of Miami, Miller School of Medicine

Board Certifications

American Board of Nuclear Medicine; American Board of Internal Medicine

Associated Clinical Trials

NCT06223789

VOLT-AF IDE Study

Icon for trial | ABT-CIP-10514 VOLT-AF IDE Study

This study is currently enrolling.

The Volt PFA System is an investigational device. This means that it is not yet approved for commercial use to treat atrial fibrillation, but it is approved for use in this Study. The Volt PFA System has gone through extensive ...